Balance Sheet APT Medical Inc.

Equities

688617

CNE100004C45

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 09/09/2024			5-day change	1st Jan Change
351.90 ^CNY	-5.00%		+1.99%	+31.34%

08-23	APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%	MT
08-22	APT Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

e362e75522507823b.0MdiEzPyGXJ6nCCo_TS6fTxOHRmKI9TOqGph2Gyvgb8.tKIrewO1XEESxnTem3WKC3MITWz7aYv-kDIFjB3K0PW5k1F6dpBMJCz7EA

Published financial data: APT MEDICAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	404M	478M	823M	1.2B	1.64B
Other Revenues, Total	-	1.5M	5.82M	11.55M	8.49M
Total Revenues	404M	479M	829M	1.22B	1.65B
Cost of Goods Sold, Total	118M	142M	259M	354M	486M
Gross Profit	286M	337M	570M	862M	1.16B
Selling General & Admin Expenses, Total	122M	153M	250M	308M	387M
Provision for Bad Debts	1.09M	283K	-511K	790K	-178K
R&D Expenses	70.42M	71.9M	135M	175M	238M
Other Operating Expenses	4.26M	6.14M	8.14M	13.75M	14.52M
Other Operating Expenses, Total	198M	232M	393M	497M	639M
Operating Income	88.03M	106M	177M	365M	525M
Interest Expense, Total	-258K	-1.41M	-1.63M	-1.45M	-3.69M
Interest And Investment Income	685K	1.21M	13.26M	23.94M	27.74M
Net Interest Expenses	427K	-207K	11.64M	22.49M	24.05M
Currency Exchange Gains (Loss)	-	-431K	-1M	1.17M	2.66M
Other Non Operating Income (Expenses)	-603K	-334K	-499K	-490K	-35.61K
EBT, Excl. Unusual Items	87.85M	105M	187M	388M	552M
Impairment of Goodwill	-	-	-	-	-3.84M
Gain (Loss) On Sale Of Investments	-1.01M	-67.73K	21.72M	342K	-
Gain (Loss) On Sale Of Assets	-909	-231K	-51.8K	56.21K	11.97M
Asset Writedown	-76.92K	-	-3.5M	-10.68M	-123K
Other Unusual Items	4.59M	16.83M	16.58M	17.25M	36.83M
EBT, Incl. Unusual Items	91.36M	121M	222M	395M	596M
Income Tax Expense	13.28M	17.02M	26.7M	54.98M	74.24M
Earnings From Continuing Operations	78.08M	104M	195M	340M	522M
Net Income to Company	78.08M	104M	195M	340M	522M
Minority Interest	4.5M	6.58M	13.07M	17.86M	11.79M
Net Income - (IS)	82.57M	111M	208M	358M	534M
Net Income to Common Incl Extra Items	82.57M	111M	208M	358M	534M
Net Income to Common Excl. Extra Items	82.57M	111M	208M	358M	534M
Per Share Items
Net EPS - Basic	1.14	1.53	2.2	3.71	5.54
Basic EPS - Continuing Operations	1.14	1.53	2.2	3.71	5.54
Basic Weighted Average Shares Outstanding	72.5M	72.36M	94.51M	96.49M	96.29M
Net EPS - Diluted	1.14	1.53	2.19	3.66	5.46
Diluted EPS - Continuing Operations	1.14	1.53	2.19	3.66	5.46
Diluted Weighted Average Shares Outstanding	72.5M	72.36M	95.11M	97.95M	97.75M
Normalized Basic EPS	0.82	1	1.37	2.7	3.7
Normalized Diluted EPS	0.82	1	1.37	2.66	3.65
Dividend Per Share	-	0.34	0.69	1.14	1.38
Payout Ratio	7.23	1.28	15.97	19.28	21.02
Supplemental Items
EBITDA	103M	125M	204M	405M	580M
EBITA	89.76M	108M	177M	367M	528M
EBIT	88.03M	106M	177M	365M	525M
EBITDAR	105M	128M	205M	406M	581M
Total Revenues (As Reported)	404M	479M	829M	1.22B	1.65B
Effective Tax Rate - (Ratio)	14.54	14.04	12.05	13.91	12.45
Total Current Taxes	13.85M	17.33M	34.9M	55.62M	79.14M
Total Deferred Taxes	-565K	-307K	-8.2M	-642K	-4.9M
Normalized Net Income	59.41M	72.01M	130M	260M	357M
Interest Capitalized	-	131K	82.6K	-	-
Interest on Long-Term Debt	-	-	522K	436K	693K
Supplemental Operating Expense Items
Marketing Expenses	-	21.01M	33M	41.59M	46.16M
Selling and Marketing Expenses	88.97M	114M	195M	241M	305M
General and Administrative Expenses	33.03M	39.56M	55.12M	66.55M	82.26M
Research And Development Expense From Footnotes	70.42M	71.9M	135M	175M	238M
Net Rental Expense, Total	1.96M	2.3M	741K	726K	933K
Imputed Operating Lease Interest Expense	54.32K	321K	237K	170K	387K
Imputed Operating Lease Depreciation	1.9M	1.98M	505K	556K	547K
Stock-Based Comp., R&D Exp. (Total)	-	-	9.17M	11.43M	8.96M
Stock-Based Comp., S&M Exp. (Total)	-	-	4.06M	4.09M	3.46M
Stock-Based Comp., G&A Exp. (Total)	-	-	3.96M	4.63M	5.07M
Stock-Based Comp., Other (Total)	2.57M	-	971K	1.6M	829K
Total Stock-Based Compensation	2.57M	-	18.17M	21.75M	18.32M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	73.52M	120M	310M	251M	1.28B
Trading Asset Securities, Total	-	-	914M	881M	60M
Total Cash And Short Term Investments	73.52M	120M	1.22B	1.13B	1.34B
Accounts Receivable, Total	47.06M	43.72M	34.01M	47.15M	41.78M
Other Receivables	3.52M	5.97M	13.45M	14.14M	8.76M
Total Receivables	50.58M	49.69M	47.46M	61.29M	50.54M
Inventory	143M	145M	263M	338M	328M
Other Current Assets, Total	7.4M	34.96M	19.15M	26.01M	41.18M
Total Current Assets	274M	350M	1.55B	1.56B	1.76B
Gross Property Plant And Equipment	191M	229M	363M	466M	668M
Accumulated Depreciation	-57.22M	-73.51M	-105M	-147M	-204M
Net Property Plant And Equipment	133M	155M	259M	320M	464M
Long-term Investments	13.09M	42.81M	121M	178M	160M
Goodwill	-	-	-	-	48.13M
Other Intangibles, Total	104M	32.47M	32.38M	38.92M	83M
Deferred Tax Assets Long-Term	1.31M	1.62M	9.82M	12.64M	10.73M
Deferred Charges Long-Term	1.07M	1.62M	7.41M	5.09M	5.95M
Other Long-Term Assets, Total	34.03M	4.82M	30.24M	114M	44.83M
Total Assets	561M	589M	2.01B	2.23B	2.57B
Liabilities
Accounts Payable, Total	9.29M	8.19M	18M	34.65M	29.56M
Accrued Expenses, Total	50.74M	62.16M	94.76M	119M	161M
Short-term Borrowings	33.8M	10.5M	16M	30M	70M
Current Portion of Long-Term Debt	-	5M	6.09M	7.27M	1.18M
Current Portion of Leases	-	-	7.46M	6.26M	10.1M
Current Income Taxes Payable	159K	3.38M	9.35M	13.3M	19.86M
Unearned Revenue Current, Total	-	16.71M	32.32M	38.65M	44.4M
Other Current Liabilities	7.48M	3.48M	10.55M	163M	252M
Total Current Liabilities	101M	109M	195M	412M	588M
Long-Term Debt	104M	23.59M	10.23M	1.77M	591K
Long-Term Leases	-	-	6.8M	7.29M	7.99M
Unearned Revenue Non Current	9.6M	5.62M	7.3M	7.06M	8.74M
Deferred Tax Liability Non Current	-	-	3.16M	6.92M	5.49M
Total Liabilities	215M	139M	222M	435M	611M
Common Stock, Total	50M	50M	66.67M	66.67M	66.86M
Additional Paid In Capital	159M	159M	1.27B	1.01B	724M
Retained Earnings	140M	251M	425M	717M	1.14B
Treasury Stock	-	-	-	-59.99M	-59.99M
Comprehensive Income and Other	-	-8.21K	17.89M	27.22M	34.96M
Total Common Equity	350M	460M	1.78B	1.76B	1.91B
Minority Interest	-3.69M	-10.27M	12.95M	27.75M	54.86M
Total Equity	346M	450M	1.79B	1.79B	1.96B
Total Liabilities And Equity	561M	589M	2.01B	2.23B	2.57B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	72.5M	72.5M	96.67M	96.22M	96.5M
ECS Total Common Shares Outstanding	72.5M	72.5M	96.67M	96.22M	96.5M
Book Value / Share	4.82	6.35	18.39	18.33	19.76
Tangible Book Value	246M	428M	1.75B	1.72B	1.78B
Tangible Book Value Per Share	3.39	5.9	18.06	17.92	18.4
Total Debt	138M	39.09M	46.58M	52.59M	89.86M
Net Debt	64.35M	-81.25M	-1.18B	-1.08B	-1.25B
Debt Equivalent Oper. Leases	15.65M	18.42M	5.93M	5.81M	7.47M
Minority Interest, Total (Incl. Fin. Div)	-3.69M	-10.27M	12.95M	27.75M	54.86M
Equity Method Investments, Total	13.09M	12.81M	57.27M	84.83M	38.66M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	104M	99.49M	174M	218M	201M
Inventories - Work In Process, Total	4.28M	9.94M	32.18M	47.84M	56M
Inventories - Finished Goods, Total	8.21M	26.73M	61.22M	71.58M	82.72M
Inventories - Others	26.16M	9.4M	2.43M	4.99M	3.29M
Buildings, Total	49.29M	69.27M	81.94M	150M	173M
Machinery, Total	22.08M	142M	224M	277M	403M
Full Time Employees	-	983	1.51K	1.74K	2.16K
Accumulated Allowance for Doubtful Accounts (Supple)	3.02M	3.22M	2.64M	3.45M	3.28M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	82.57M	111M	208M	358M	534M
Depreciation & Amortization - CF	12.95M	17.5M	32.43M	45.96M	60.38M
Amortization of Goodwill and Intangible Assets - (CF)	1.73M	2.31M	750K	1.56M	3.63M
Depreciation & Amortization, Total	14.68M	19.81M	33.18M	47.52M	64.01M
Amortization of Deferred Charges, Total - (CF)	651K	934K	1.37M	3.96M	3.88M
(Gain) Loss From Sale Of Asset	909	-336	-16.58K	-56.21K	-10.81M
(Gain) Loss on Sale of Investments - (CF)	1.01M	67.73K	-32.82M	-21.09M	-23.13M
Asset Writedown & Restructuring Costs	349K	239K	9.81M	10.68M	3.97M
Provision for Credit Losses	-	470K	-	-	-
Provision and Write-off of Bad Debts	1.09M	-	-511K	790K	-178K
Other Operating Activities, Total	-3.76M	-5.32M	-10.11M	-13.45M	906K
Change In Accounts Receivable	-60.56M	25.33M	4.3M	-23.17M	20M
Change In Inventories	-62.74M	-2.44M	-124M	-72.59M	11.22M
Change In Accounts Payable	80.98M	-477K	82.51M	61.71M	68.9M
Change In Deferred Taxes	-565K	-307K	-8.2M	939K	-4.9M
Change in Other Net Operating Assets	1.17M	-849K	18.17M	14.19M	21.28M
Cash from Operations	54.9M	148M	181M	367M	689M
Capital Expenditure	-67.56M	-44.2M	-167M	-143M	-202M
Sale of Property, Plant, and Equipment	834K	12K	36.03K	229K	12.67M
Cash Acquisitions	-	-	-	-	-46.37M
Investment in Marketable and Equity Securities, Total	-2M	-30M	-948M	-39.16M	798M
Other Investing Activities, Total	708K	74.92M	4.93M	47.61M	19.82M
Cash from Investing	-68.02M	730K	-1.11B	-135M	582M
Long-Term Debt Issued, Total	41.5M	16.41M	48.5M	82.6M	70M
Total Debt Issued	41.5M	16.41M	48.5M	82.6M	70M
Long-Term Debt Repaid, Total	-13.2M	-115M	-30.27M	-84.16M	-49.62M
Total Debt Repaid	-13.2M	-115M	-30.27M	-84.16M	-49.62M
Issuance of Common Stock	-	-	1.2B	19M	34.67M
Repurchase of Common Stock	-	-	-	-59.99M	-
Common Dividends Paid	-5.97M	-1.41M	-33.19M	-69.01M	-112M
Common & Preferred Stock Dividends Paid	-5.97M	-1.41M	-33.19M	-69.01M	-112M
Other Financing Activities, Total	-25.57M	-1.43M	-64.99M	-183M	-189M
Cash from Financing	-3.23M	-102M	1.12B	-295M	-246M
Foreign Exchange Rate Adjustments	-883K	-527K	-1.02M	958K	2.84M
Net Change in Cash	-17.24M	46.83M	189M	-60.71M	1.03B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	34.39M	52.64M	78.34M	146M	204M
Levered Free Cash Flow	-49.51M	38.85M	-34.12M	265M	354M
Unlevered Free Cash Flow	-49.35M	39.73M	-33.1M	266M	356M
Change In Net Working Capital	54.71M	2.85M	28.87M	-108M	-144M
Net Debt Issued / Repaid	28.3M	-98.78M	18.23M	-1.56M	20.38M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	12.41	11.49	8.49	10.76	13.67
Return on Total Capital	14.38	13.57	9.49	12.39	16.84
Return On Equity %	25.32	26.18	17.39	18.99	27.82
Return on Common Equity	26.66	27.35	18.58	20.22	29.09
Margin Analysis
Gross Profit Margin %	70.75	70.35	68.74	70.89	70.54
SG&A Margin	30.2	31.98	30.22	25.29	23.45
EBITDA Margin %	25.43	26.17	24.65	33.3	35.15
EBITA Margin %	22.22	22.52	21.41	30.14	32.03
EBIT Margin %	21.79	22.04	21.32	30.02	31.81
Income From Continuing Operations Margin %	19.33	21.73	23.51	27.97	31.64
Net Income Margin %	20.44	23.11	25.09	29.44	32.35
Net Avail. For Common Margin %	20.44	23.11	25.09	29.44	32.35
Normalized Net Income Margin	14.71	15.02	15.67	21.42	21.6
Levered Free Cash Flow Margin	-12.26	8.1	-4.12	21.81	21.45
Unlevered Free Cash Flow Margin	-12.22	8.29	-3.99	21.89	21.59
Asset Turnover
Asset Turnover	0.91	0.83	0.64	0.57	0.69
Fixed Assets Turnover	3.45	3.32	4	4.2	4.21
Receivables Turnover (Average Receivables)	11.15	10.53	21.17	29.68	36.92
Inventory Turnover (Average Inventory)	1.06	0.99	1.27	1.18	1.46
Short Term Liquidity
Current Ratio	2.7	3.2	7.98	3.78	2.99
Quick Ratio	1.22	1.55	6.53	2.9	2.36
Operating Cash Flow to Current Liabilities	0.54	1.35	0.93	0.89	1.17
Days Sales Outstanding (Average Receivables)	32.74	34.76	17.24	12.3	9.89
Days Outstanding Inventory (Average Inventory)	344.74	370.94	287.77	309.9	249.98
Average Days Payable Outstanding	16.26	22.12	12.68	22.41	24.61
Cash Conversion Cycle (Average Days)	361.22	383.58	292.33	299.78	235.25
Long Term Solvency
Total Debt/Equity	39.86	8.69	2.6	2.94	4.58
Total Debt / Total Capital	28.5	7.99	2.53	2.85	4.38
LT Debt/Equity	30.09	5.24	0.95	0.51	0.44
Long-Term Debt / Total Capital	21.51	4.82	0.93	0.49	0.42
Total Liabilities / Total Assets	38.35	23.55	11.03	19.54	23.75
EBIT / Interest Expense	341.76	74.77	108.65	251.42	142.29
EBITDA / Interest Expense	398.76	88.79	129.06	284.15	159.64
(EBITDA - Capex) / Interest Expense